Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

Paul M. McKeigue; David A. McAllister; Jen Bishop; Sharon Hutchinson; Chris Robertson; Nazir Lone; Jim McMenamin; David Goldberg; Helen M. Colhoun

doi:10.12688/f1000research.53812.1

Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

Paul M. McKeigue, David A. McAllister, Jen Bishop, Sharon Hutchinson, Chris Robertson, Nazir Lone, Jim McMenamin, David Goldberg, Helen M. Colhoun

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	663
Journal	F1000Research
Volume	10
DOIs	https://doi.org/10.12688/f1000research.53812.1
Publication status	Published - 2021
Externally published	Yes

ASJC Scopus Subject Areas

General Biochemistry,Genetics and Molecular Biology
General Immunology and Microbiology
Pharmacology, Toxicology and Pharmaceutics(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.12688/f1000research.53812.1

Cite this

@article{f880ec8aaedb48928c19ff0d7644ecb0,

title = "Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland",

author = "McKeigue, {Paul M.} and McAllister, {David A.} and Jen Bishop and Sharon Hutchinson and Chris Robertson and Nazir Lone and Jim McMenamin and David Goldberg and Colhoun, {Helen M.}",

note = "Funding Information: No specific funding was received for this study. Professor Colhoun is supported by an endowed chair from the AXA Research Foundation. Publisher Copyright: Copyright: {\textcopyright} 2021 McKeigue PM et al.",

year = "2021",

doi = "10.12688/f1000research.53812.1",

language = "English",

volume = "10",

journal = "F1000Research",

issn = "2046-1402",

publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

AU - McKeigue, Paul M.

AU - McAllister, David A.

AU - Bishop, Jen

AU - Hutchinson, Sharon

AU - Robertson, Chris

AU - Lone, Nazir

AU - McMenamin, Jim

AU - Goldberg, David

AU - Colhoun, Helen M.

N1 - Funding Information: No specific funding was received for this study. Professor Colhoun is supported by an endowed chair from the AXA Research Foundation. Publisher Copyright: Copyright: © 2021 McKeigue PM et al.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85153033784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85153033784&partnerID=8YFLogxK

U2 - 10.12688/f1000research.53812.1

DO - 10.12688/f1000research.53812.1

M3 - Article

AN - SCOPUS:85153033784

SN - 2046-1402

VL - 10

JO - F1000Research

JF - F1000Research

M1 - 663

ER -

Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this